Rainbow Medical Investment Company

23/01/2019

Pythagoras Medical ConfidenHT study publication as published in the EuroIntervention Journal on Dec. 20, 2018:

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

05/09/2018

As renal denervation procedures are making a comeback in treating resistant hypertension, Vascular Dynamics is going a different route to tackle the condition, by developing a stent-like application that will give therapy to patients.

14/06/2018

BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug Administration (FDA) has approved the company's pivotal study design for its RENOVA iStim™ system to support its marketing

26/03/2018

Pythagoras Medical Receives CE-Mark for the ConfidenHT™ System

HERTSLIYA, Israel, March 26, 2018 /PRNewswire/ --Unique nerve mapping technology for renal denervation (RDN)...

14/12/2017

Enopace Biomedical Voted # 1 Medical Innovation Company!

This is "TCT 2017 Shark Tank Competition Winner" by CRF on Vimeo, the home for high quality videos and the people who love them.

06/12/2017

Enopace Biomedical Voted # 1 Medical Innovation Company!

04/12/2017

Please join us at 16:36, Hall 'A' for a presentation of Pythagoras's 'CONFIDENT' System - Renal Nerve Mapping Using Electrical Stimulation

the ICI conference
https://events.eventact.com/ProgramView/ProgramOverview.aspx?Event=28605&Agenda=11323

03/12/2017

Please join us for this session at 11:30 "Epicardial Access - Under Vision" - at ICI meeting 2017.

Initial Experience with a New Self-expanding THV-technology to Treat Native Aortic Stenosis and Degenerated Small Surgical Bioprosthetical Valves

01/11/2017

The good news of the day...

http://www.rainbowmd.com/wp-content/uploads/2017/11/10302017-TCT-2017.pdf

03/09/2017

https://globenewswire.com/news-release/2017/08/28/1100983/0/en/Interim-Data-on-MobiusHD-Presented-at-the-European-Society-of-Cardiology-Shows-Promise-in-the-Treatment-of-Resistant-Hypertension.html

MOUNTAIN VIEW, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announced interim results of the company’s first-in-human trial of its MobiusHD implant presented in a p...

23/08/2017

FDA 批准 Vascular Dynamics 的治疗顽固性高血压的 MobiusHD® 系统进行 CALM 2实验

23/08/2017

חברת Vascular Dynamics מקבוצת ההשקעות Rainbow Medical קיבלה אישור FDA להתחיל בניסוי הסופי והמכריע במוצר הדגל לטיפול בעודף לחץ דם כרוני

http://www.rainbowmd.com/wp-content/uploads/2017/08/VDI-16.18.17-שעה-4.19-סופי.pdf